Morgan Stanley resumes coverage of Metlife (MET) with an Overweight
More News related to MET
- Brennan Financial Group Welcomes New Financial Representatives
- Y Worry? Gen Y Optimistic about Recovery, Looking for Guidance, MetLife Survey Shows
- MetLife Expands Its Dental Continuing Education Program
- FBR Research Maintains a 'Market Perform' on MetLife (MET); Raises PT
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
More News related to New Coverage
- Morgan Stanley Initiates Coverage on Williams Companies (WMB) with an Overweight
- Morgan Stanley Starts ONEOK (OKE) at Underweight, $40 Price Target
- Broadpoint.Amtech Initiates Coverage on Willbros Group (WG) with a Buy; Leading North American Pipeline Contractor
- Miller Tabak Initiates Coverage on Oclaro (OCLR) with a Buy
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
Morgan Stanley resumes coverage of Metlife (NYSE: MET) with an Overweight rating.
MetLife, Inc., through its subsidiaries, provides insurance and other financial services principally in the United States, Latin America, Europe, and Asia Pacific.
Related Categories
New CoverageStocks Mentioned
+0.79Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
